Skip to main content
ADALTA LIMITED logo

ADALTA LIMITED — Investor Relations & Filings

Ticker · 1AD ISIN · AU0000001AD2 LEI · 254900XT3BQIT6GR6M94 ASX Professional, scientific and technical activities
Open in API
Filings indexed 726 across all filing types
Latest filing 2024-05-12 Capital/Financing Update
Country AU Australia
Listing ASX 1AD

About ADALTA LIMITED

https://adalta.com.au/

AdAlta Limited is a clinical-stage biotechnology company focused on the discovery and development of a new class of protein therapeutics called i-bodies. The company utilizes its proprietary i-body platform to engineer highly stable, small-format proteins that mimic the binding characteristics of shark antibodies. These i-bodies are designed to target complex disease-related proteins that are often inaccessible to traditional monoclonal antibodies. AdAlta's lead therapeutic candidate, AD-214, is being developed for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic conditions. The platform's versatility allows for the creation of diverse therapeutic leads across multiple disease areas, including inflammation and oncology, by leveraging the unique structural properties of the human protein scaffold-based i-body library.

Recent filings

Filing Released Lang Actions
Cellular immunotherapy manufacturer secured - Cell Therapies 4 pages 216.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 May 2024 from AdAlta Limited. It details a new Master Services Agreement (MSA) with Cell Therapies Pty Ltd to establish CTPL as the preferred manufacturer of cellular immunotherapies for AdAlta's collaboration AdCella. The content focuses on the partnership, manufacturing capabilities, strategic goals, and background information about the companies involved. There are no financial statements, quarterly or annual results, nor any regulatory certifications or voting results. The document is a corporate announcement about a strategic partnership and manufacturing arrangement, which fits best under Capital/Financing Update (CAP) as it relates to business development and operational collaboration impacting company capital and resources. The document length (13,347 characters) and detailed content confirm it is not a brief report publication announcement or a simple regulatory filing. Therefore, the classification is CAP with high confidence.
2024-05-12 English
Application for quotation of securities - 1AD 6 pages 18.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the number and type of securities to be quoted, issue dates, and references previous announcements (Appendix 3B) related to the securities issuance. The document is a formal announcement related to capital market activities, specifically the quotation of new securities following a prior issue. It does not contain financial statements, management discussion, or audit information. It is not a report but an official announcement related to capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2024-05-08 English
Cleansing Notice under Section 708A 1 page 275.0KB
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement regarding the issuance of shares by AdAlta Ltd under section 708A(5)(e) of the Corporations Act 2001. It notifies the market about the issuance of fully paid ordinary shares without disclosure under Part 6D.2 of the Act and confirms compliance with relevant provisions. The document is brief (1163 characters) and serves as a regulatory notice about a capital transaction rather than a full report or detailed financial disclosure. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other filing types.
2024-05-08 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities on the ASX (Australian Securities Exchange). It includes information about securities issued due to options being exercised or convertible securities being converted, the number of securities to be quoted, issue dates, and other related details. This type of document is a formal announcement related to the issuance and quotation of new securities, which corresponds to announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (5614 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2024-05-06 English
Investor webinar presentation 10 pages 2.8MB
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation" and contains detailed strategic information about AdAlta Limited's growth plans, development programs, investment terms, and business models. It includes financial and operational updates but is structured as a presentation rather than a formal financial report. There is no indication of comprehensive financial statements or regulatory filing formats such as 10-K or interim reports. The presence of slides, strategic outlook, and investment highlights aligns with the characteristics of an Investor Presentation (IP). The document length (10,448 characters) supports a detailed presentation rather than a brief announcement or a full annual report. Therefore, the most appropriate classification is Investor Presentation (IP).
2024-04-30 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Adalta Limited regarding the application for quotation of securities on the ASX. It details the securities issued as a result of options being exercised or convertible securities being converted, including the number of securities, issue dates, and other related information. This type of document is a formal application to list or quote new securities on the exchange, which corresponds to announcements about new share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is over 5,000 characters and contains substantive details about the securities issued, supporting this classification with high confidence.
2024-04-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.